Enalapril maleate oral solution (enalapril maleate) NDC 72603-247

NDC codes

FDA NDC Directory

Product NDC (as listed)72603-247Labeler and product segments. Claims need a package NDC.

Product NDC at billing width72603-0247Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
72603-247-01	72603024701	1 BOTTLE in 1 CARTON (72603-247-01) / 150 mL in 1 BOTTLEMarketed from May 1, 2024

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Enalapril maleate oral solution
Generic name (nonproprietary): enalapril maleate
Active ingredients: Enalapril maleate — 1 mg/mL
Dosage form: Solution
Route: Oral
Labeler: NorthStar RxLLC
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 214467
Marketing start: May 1, 2024
Listing expires: Dec 31, 2026
Other FDA classes: Angiotensin-converting Enzyme Inhibitors (Mechanism)Decreased Blood Pressure (Physiologic effect)
Identifiers: Product ID 72603-247_16595fbf-a903-56fc-e063-6294a90a4710SPL ID 16595fbf-a903-56fc-e063-6294a90a4710SPL set ID 19606da3-c6b0-40a5-9690-77fc37072b51RxCUI 1435624UNII 9O25354EPJUPC 0372603247015
Pharmacologic class: Angiotensin Converting Enzyme Inhibitor

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N472603024701 followed by a unit qualifier and the quantity

Package 72603-0247-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Apr 18, 2024. This label includes a boxed warning.

Indications (excerpt from the label)

Enalapril maleate is an angiotensin-converting enzyme inhibitor indicated for: • treatment of hypertension in adults and children older than one month, to lower blood pressure. Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. ( 1.1 ) • treatment of symptomatic heart failure. ( 1.2 ) • treatment of asymptomatic left ventricular dysfunction, to decrease the rate of development of overt heart failure and reduce hospitalization for heart failure. ( 1.3 ) 1.1 Hypertension Enalapril maleate oral solution is indicated for the treatment of hypertension, to lower blood pressure in adults and children older than one mon…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 214467

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 214467
Product	Strength	Form · route	Labeler	Product NDC
Enalapril maleate oral solutionenalapril maleate	Enalapril maleate 1 mg/mL	SolutionOral	Camber Pharmaceuticals, Inc.	31722-020